Hanmi Financial reports record FY2022 net income of $101.4M; Q4 EPS $0.93, up 4.8% QoQ

HANMI FINANCIAL CORP

2022-FY EPS reported $3.32 revenue$271,847,000

Full year 2022 net income $101.4M ($3.32 diluted EPS) vs $98.7M in 2021, up 2.8%.
Q4 net income $28.5M ($0.93 diluted EPS), up 4.8% from Q3; net interest margin 3.67%.
Loans receivable $5.97B (+2.9% QoQ, +15.8% YoY); full year loan production $2.12B, up 17.1% ex-PPP.
Deposits $6.17B; noninterest-bearing deposits 41.2%; criticized loans down 26.7% QoQ to $125.2M.
Capital ratios: CET1 11.37%, Total capital 14.49%; nonperforming assets declined to $10.0M.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

HANMI FINANCIAL CORP reported the full year 2022 results: net income $101.4 million, EPS $3.32 per diluted share.

Period: the full year 2022
Net income: $101.4 million
EPS: $3.32 per diluted share
Result: reported results

Exact text from the filing

For the full year 2022, net income was $101.4 million, or $3.32 per diluted share

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

HANMI FINANCIAL CORP reported the fourth quarter of 2022 results: net income $28.5 million, EPS $0.93 per diluted share.

Period: the fourth quarter of 2022
Net income: $28.5 million
EPS: $0.93 per diluted share
Result: reported results

Exact text from the filing

Net income for the fourth quarter of 2022 was $28.5 million, or $0.93 per diluted share

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

HANMI FINANCIAL CORP filing history →

Source: SEC EDGAR

accession 0001171843-23-000440

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.